Company: TELO
Filing Date: 2025-02-04
Form Type: 10-K
Source: 0001493152-25-004872
Chunk: 92

Company: Telomir Pharmaceuticals, Inc.
Filing Date: 2025-02-04
Form: 10-K
Item: Item 9B
Chunk 92
---
0.064 million and $0.034 million, respectively.

Additionally,
the Company appointed a new audit firm, Salberg & Company P.A (“Salberg”) effective December 19, 2024. The aggregate
fees billed by Salberg for professional services rendered for the audit of our annual financial statements, and other required filings
with the SEC for the year ended December 31, 2024 totaled $0.05 million

The
above amounts include interim procedures and audit fees, as well as attendance at audit committee meetings.

Audit-Related
Fees. The aggregate fees billed by Cherry Bekaert LLP for audit-related fees for the years ended December 31, 2024 and 2023 were
$0.051 million and $0.036 million, respectively. The fees were provided in consideration of services consisting of review and update
procedures associated with registration statements and other SEC filings.

Tax
Fees. There were no fees billed by Salberg & Company P.A for tax services.

All
Other Fees. None

The
Audit Committee of our board of directors has established its pre-approval policies and procedures, pursuant to which the Audit Committee
approved the foregoing audit and non-audit services provided by Cherry Bekaert LLP and Salberg & Company P.A in 2024 . Consistent
with the Audit Committee’s responsibility for engaging our independent auditors, all audit and permitted non-audit services require
pre-approval by the Audit Committee. The full Audit Committee approves proposed services and fee estimates for these services. The Audit
Committee chairperson has been designated by the Audit Committee to approve any audit-related services arising during the year that were
not pre-approved by the Audit Committee. Any non-audit service must be approved by the full Audit Committee. Services approved by the
Audit Committee chairperson are communicated to the full Audit Committee at its next regular meeting and the Audit Committee reviews
services and fees for the fiscal year at each such meeting. Pursuant to these procedures, the Audit Committee approved the foregoing
services provided by Cherry Bekaert LLP and Salberg & Company P.A.

72

PART
IV

Item
15. Exhibits, Financial Statement Schedules.

The
information called for by this Item is incorporated herein by reference to the Exhibit Index in this Form 10-K.

INDEX
TO EXHIBITS

    Exhibit
    No.
     
    Exhibit
    Description
  
    3.1
     
    Second Amended and Rest